Anastrozole
Also known as: Arimidex
Non-steroidal aromatase inhibitor used on cycle to control estradiol from aromatization — powerful, and easy to overdo, so it belongs on lab-guided, minimal dosing.
Substance family
They block the enzyme that converts androgens to estrogens. The recurring error is using them without measuring — estradiol that is too low causes symptoms confusingly similar to estradiol that is too high.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
This substance causes
This substance works against
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
Estradiol control (on cycle)
AncillaryDose
0.25–0.5 mg, individual
Frequency
Every other day to twice weekly
Cycle length
As needed during aromatizing cycles
Highly individual — titratetitrateAdjusting a dose stepwise against a measured result rather than setting it in advance. to a sensitive estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range. test, do not dose blindly.
Side effect & countermeasure
Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.
Problem
Crashed estradiol (dosed too high)
Countermeasure
Reduce or stop the dose; symptoms like joint pain, low libido and lethargy signal estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range. is too low. Confirm with a sensitive estradiol test.
Problem
Worsened lipid profile (HDL down)
Countermeasure
Use the lowest effective dose; support with cardio, Omega-3 and Citrus Bergamot, and monitor lipids.
Problem
Estradiol reading looks absurdly high
Countermeasure
Check which assay was used. The standard immunoassay is unreliable in men and reads high; only a sensitive assay (LC-MS/MS) gives a number worth dosing against.
Problem
Symptoms persist despite the aromatase inhibitor
Countermeasure
Check whether the compound aromatizesaromatizesThe body converting testosterone into estrogen via the aromatase enzyme. at all. Nandrolone is progestogenicprogestogenicActing on the progesterone receptor — a property of 19-nor compounds that causes estrogen-like problems without high estradiol. and trenbolone does not aromatize — an AIAIA drug that blocks the conversion of testosterone to estradiol. cannot fix either, and prolactinprolactinA pituitary hormone that, when elevated, causes low libido, erectile problems and breast tissue growth. is the marker to look at instead.
Overview
Anastrozole is a non-steroidal aromatase inhibitor. In the enhancement context it is used to limit the conversion of testosterone to estradiol during aromatizing cycles. It is effective and easy to overdo — crashing estradiol causes its own set of problems, and they are worse than the ones people take it to avoid.
Mechanism of Action
It blocks the aromatase enzyme, reducing the production of estradiol from androgens. Because estradiol is important for joints, libido, mood, bone and lipids, the goal is control, not elimination.
Worth being explicit about what it is for: estradiol rises because aromatizable androgens are present in quantity. The aromatase inhibitor treats that consequence. The dose driving it is the cause.
Get the right test first
More harm comes from acting on a bad number than from the drug itself.
The standard estradiol test most labs run by default is an immunoassay developed for women, where levels are far higher. In men it is unreliable and tends to read high. Someone tests, sees an alarming figure, takes an aromatase inhibitor they never needed, and crashes.
What you want is a sensitive estradiol assay — usually LC-MS/MS, often listed as "estradiol, sensitive" or "ultrasensitive". If the lab report does not say which method was used, the number is not worth dosing against.
The half-life trap
Anastrozole has a half-life of roughly two days, which means the level keeps climbing for about a week and a half before it settles.
This causes a predictable mistake. Someone takes a dose, feels nothing after three days, takes more, still feels nothing, takes more again — and then the accumulated total arrives all at once. The crash that follows gets blamed on sensitivity to the drug rather than on stacking doses faster than the body cleared them.
Change one thing, then wait a week and a half before judging it. Retest before adjusting again.
When it cannot work
An aromatase inhibitor only does anything if there is aromatization to inhibit.
Trenbolone does not aromatize. Nandrolone barely aromatizes but is progestogenic. Symptoms that look estrogenic on either compound — nipple sensitivity, water, low libido — are usually not driven by estradiol at all, and adding an aromatase inhibitor makes matters worse by dropping what estradiol there is. On those compounds prolactin is the marker to look at.
This is one of the most common and most avoidable mistakes in the whole field: treating a symptom by its appearance instead of its mechanism.
Typical Context
Used as an ancillary during cycles that aromatize — testosterone at higher doses, primarily — ideally guided by a sensitive estradiol test alongside symptoms. Not needed on non-aromatizing compounds, and frequently not needed at all at moderate doses.
Body fat matters here too: aromatization happens largely in adipose tissue, so the same dose of testosterone produces more estradiol in someone carrying more fat. Losing fat lowers the problem at its source.
Side Effects & Risks
- Crashed estradiol: joint pain, low libido, lethargy, low mood, poor sleep
- Worsened lipid profile — HDL falls, and this adds to the drop the androgens are already causing rather than replacing it
- Reduced bone mineral density with prolonged use, since estradiol is what maintains bone in men as well
- A rebound in estradiol after stopping abruptly, as aromatase activity returns
The lipid point is the one most often shrugged off. The androgens are already pushing HDL down; the aromatase inhibitor pushes it further in the same direction. That is a cardiovascular cost accumulating quietly over years, and it is invisible without a blood test.
Blood Work & Monitoring
- Estradiol (sensitive assay) — the marker the dose is set against
- Lipid profile — HDL, LDL and triglycerides, since AIs worsen all three
- Total testosterone — for context; estradiol only means something relative to the androgen driving it
- General health panel during longer use
Harm-Reduction Notes
- Titrate to labs and symptoms; never dose blindly "just in case"
- Confirm the assay was the sensitive one before acting on any number
- The lowest effective dose is the goal — many people need very little, and some need none
- Keep estradiol in a healthy range, not as low as possible: the symptoms of too little are as bad as those of too much, and harder to recognise
- Lowering the androgen dose treats the cause; the aromatase inhibitor treats the consequence
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Prescription-only medicineApproved for defined indications; use outside them is off-label. |
| EU / UK | Prescription-only medicineApproved for defined indications. |
| Canada / Australia | Prescription-only medicine |
| Parts of Asia, Latin America & Middle East | Pharmacy availability variesSeveral countries dispense it without prescription in practice. Rules and enforcement differ and change. |
| Competitive sport | Check the current WADA listSome substances in this class are prohibited, others are not. |